MarketPulse
P

$PRPO

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Precipio Enhances Shareholder Engagement With First Live Q&A Session

Precipio adds live Q&A to Q1-2026 earnings call on May 18th, signaling enhanced commitment to shareholder transparency and investor engagement in specialty diagnostics.
PRPOcancer diagnosticsQ&A session
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Precipio Posts 30% Revenue Growth; Partners with Memorial Sloan-Kettering on Cancer Test

Cancer diagnostics firm $PRPO reports $24M in 2025 revenues, up 30% year-over-year, and publishes peer-reviewed study on its BCR::ABL1 blood test.
PRPOQ4 2025 earningsrevenue growth